Stoke Therapeutics Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $0.12 million on Dec 02 ’24. In the deal valued at $12.07 per share,10,000 shares were sold. As a result of this transaction, Ticho Barry now holds 51,277 shares worth roughly $0.59 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Ticho Barry sold 10,000 shares, generating $126,803 in total proceeds. Upon selling the shares at $12.68, the CHIEF MEDICAL OFFICER now owns 2,485 shares.
Before that, BARUCH TICHO bought 20,000 shares. Stoke Therapeutics Inc shares valued at $247,200 were divested by the Officer at a price of $12.36 per share.
A number of analysts have revised their coverage, including TD Cowen’s analysts, who increased its forecast for the stock in late March from “a Market perform” to “an Outperform”. TD Cowen revised its rating on July 25, 2023. It rated STOK as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of STOK
On Tuesday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock fall -5.30% to $11.43. Over the last five days, the stock has lost -2.97%. Stoke Therapeutics Inc shares have risen nearly 117.30% since the year began. Nevertheless, the stocks have risen 189.37% over the past one year. While a 52-week high of $17.58 was reached on 06/13/24, a 52-week low of $3.78 was recorded on 02/13/24. SMA at 50 days reached $12.40, while 200 days put it at $12.60.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 11.13, which if violated will result in even more drops to 10.83. On the upside, there is a resistance level at 11.98. A further resistance level may holdings at 12.53. The Relative Strength Index (RSI) on the 14-day chart is 38.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.38%. Stochastics %K at 21.70% indicates the stock is a holding.
How much short interest is there in Stoke Therapeutics Inc?
A steep rise in short interest was recorded in Stoke Therapeutics Inc stocks on 2024-11-15, dropping by -0.38 million shares to a total of 6.4 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 6.79 million shares. There was a decline of -5.99%, which implies that there is a negative sentiment for the stock.
